Diabetes_YHLO

YHLO

YHLO

Language

Reproductive Health

Home page

2024/06/05

Association of subclass distribution of insulin antibody with glucose control in insulin-treated type 2 diabetes mellitus a retrospective observational study

2024/06/05

Growth differentiation factor-15adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese

2024/06/05

Low Total Testosterone Levels in Men with Newly Diagnosed

2024/06/05

Clinical, hormonal, and biochemical characteristics of 70 chinese children with moderate to severe type 1 diabetic ketoacidosis

2024/06/05

Identifying gene variants underlying the pathogenesis of diabetic retinopathy based on integrated genomic and transcriptomic analysis of clinical extreme phenotypes

2024/06/05

Case Report Recurrent Autoimmune Hypoglycemia Induced by Non-Hypoglycemic Medications

2024/06/05

Prevalence and phenotypic features of diabetes due to recessive, non-syndromic WFS1 mutations

2024/06/05

Islet Autoantibody Standardization Program 2018 WorkshopInterlaboratory Comparison of Glutamic Acid Decarboxylase Autoantibody Assay Performance

2024/06/05

Advances in Biosensors for Continuous Glucose Monitoring Towards Wearables

2024/06/05

Relationships between Islet-Specific Autoantibody Titers and the Clinical Characteristics of Patients with Diabetes Mellitus

< 1 >

YHLO

Home
Products
- CLIA
  - Analyzers
  - Reagents
- Chemistry
- TLA
- LIA
- ESR
Pubilcations
- Autoimmunity
- Reproductive Health
- Diabetes
- Liver Disease
- Infection
- COVID-19
- ESR
- Others
News
- YHLO News
- Marketing Activities
About YHLO
Contact us
- Career
- Service

Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Tel: +86 755 26601910

Email: marketing@szyhlo.com

youtube

instagram

wechat

wechat

Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.

Powered by 300.cn | SEO | Business License

8

Email

marketing@szyhlo.com

9

Tel

+86 755 26601910